BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31087508)

  • 1. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis.
    Li S; Li T; Shi YQ; Xu BJ; Deng YY; Sun XG
    Cancer Biomark; 2024; 40(1):27-45. PubMed ID: 38393891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics.
    Bareja C; Dwivedi K; Uboveja A; Mathur A; Kumar N; Saluja D
    Sci Rep; 2024 Apr; 14(1):9894. PubMed ID: 38688978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis.
    Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating potential molecular mechanisms of serum exosomal miRNAs in colorectal cancer based on bioinformatics analysis.
    Wang H; Chen X; Bao L; Zhang X
    Medicine (Baltimore); 2020 Sep; 99(37):e22199. PubMed ID: 32925795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and prognostic analysis of candidate biomarkers for lung metastasis in colorectal cancer.
    Liu Y; Liu C; Huang D; Ge C; Chen L; Fu J; Du J
    Medicine (Baltimore); 2024 Mar; 103(11):e37484. PubMed ID: 38489730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and verification of key cancer genes associated with prognosis of colorectal cancer based on bioinformatics analysis.
    Qin Y; Chen L; Chen L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 46(10):1063-1070. PubMed ID: 34911835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An age stratified analysis of the biomarkers in patients with colorectal cancer.
    Yao H; Li C; Tan X
    Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence.
    Wu Z; Liu Z; Ge W; Shou J; You L; Pan H; Han W
    Cancer Med; 2018 Jun; 7(6):2555-2566. PubMed ID: 29659199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of EDNRA as the Key Biomarker for Hypercholesterolemia and Colorectal Cancer.
    Han K; He Z; Liu Y; Chen H
    Tohoku J Exp Med; 2024 Mar; 262(3):181-189. PubMed ID: 38123303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Molecular Biomarkers and Key Pathways for Esophageal Carcinoma (EsC): A Bioinformatics Approach.
    Islam MR; Alam MK; Paul BK; Koundal D; Zaguia A; Ahmed K
    Biomed Res Int; 2022; 2022():5908402. PubMed ID: 35071597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Prognostic Biomarkers for Colorectal Cancer by Bioinformatics Analysis.
    Niu C; Li X; Lei Luo X; Wan H; Jin W; Zhang Z; Zhang W; Li B
    Turk J Gastroenterol; 2024 Jan; 35(1):61-72. PubMed ID: 38454278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation.
    Hosseini ST; Nemati F
    Sci Rep; 2023 Oct; 13(1):17086. PubMed ID: 37816854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential key genes for colorectal cancer based on bioinformatics analysis.
    Li C; Cao S; Guo M; Guo A; Sun X
    Medicine (Baltimore); 2023 Dec; 102(51):e36615. PubMed ID: 38134110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RRP9 and DDX21 as new biomarkers of colorectal cancer.
    Chi X; Yang N; Liu Y
    Medicine (Baltimore); 2023 Oct; 102(43):e34384. PubMed ID: 37904456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening out molecular pathways and prognostic biomarkers of ultraviolet-mediated melanoma through computational techniques.
    Hossain A; Ahsan A; Hasan I; Sohel ; Khan A; Somadder PD; Monjur S; Miah S; Kibria KMK; Ahmed K; Rahman H
    Int J Biol Markers; 2024 Jun; 39(2):118-129. PubMed ID: 38410032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis to identify breast cancer-related potential targets and candidate small molecule drugs.
    Hong H; Chen H; Zhao J; Qin L; Li H; Huo H; Shi S
    Mutat Res; 2023; 827():111830. PubMed ID: 37437506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes, pathways and potential therapeutic agents for IgA nephropathy using an integrated bioinformatics analysis.
    Chen X; Sun M
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320919635. PubMed ID: 32370650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis.
    Chen L; Ke X
    Medicine (Baltimore); 2021 Mar; 100(9):e24953. PubMed ID: 33655961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis to identify novel potential biomarkers as drug targets in colorectal cancer therapy: an integrated bioinformatics analysis.
    Gatasheh MK; Natarajan SR; Krishnamoorthy R; Alsulami TS; Rajagopal P; Palanisamy CP; Veeraraghavan VP; Jayaraman S
    Mol Cell Oncol; 2024; 11(1):2326699. PubMed ID: 38505173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.